Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
+$168M |
| 2 |
Exxon Mobil
XOM
|
+$120M |
| 3 |
GE HealthCare
GEHC
|
+$103M |
| 4 |
Visa
V
|
+$96.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$92.1M |
Top Sells
| 1 |
Walmart
WMT
|
+$331M |
| 2 |
JPMorgan Chase
JPM
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$102M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$98.9M |
| 5 |
ConocoPhillips
COP
|
+$80.4M |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.03% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Caribou Biosciences
CRBU
$169M
| $1.13M | ﹤0.01% |
213,283
+91,478
| +75% | +$486K |
|
2877
Aclaris Therapeutics
ACRS
$231M
| $1.12M | ﹤0.01% |
137,923
+89,906
| +187% | +$727K |
|
2878
Cabaletta Bio
CABA
$150M
| $1.11M | ﹤0.01% |
134,757
+9,249
| +7% | +$76.5K |
|
2879
Five Star Bancorp
FSBC
$696M
| $1.11M | ﹤0.01% |
52,044
+19,242
| +59% | +$411K |
|
2880
Ecopetrol
EC
$18.8B
| $1.1M | ﹤0.01% |
104,567
+26,373
| +34% | +$278K |
|
2881
Impinj
PI
$5.84B
| $1.1M | ﹤0.01% |
8,103
-4,337
| -35% | -$588K |
|
2882
Enel Chile
ENIC
$4.95B
| $1.09M | ﹤0.01% |
410,056
+3,371
| +0.8% | +$8.97K |
|
2883
Northeast Community Bancorp
NECB
$277M
| $1.09M | ﹤0.01% |
83,119
+464
| +0.6% | +$6.09K |
|
2884
Atlantic American Corp
AAME
$65.7M
| $1.09M | ﹤0.01% |
444,769
-5,589
| -1% | -$13.7K |
|
2885
Mizuho Financial
MFG
$82.4B
| $1.09M | ﹤0.01% |
386,038
+19,118
| +5% | +$53.9K |
|
2886
Neuronetics
STIM
$244M
| $1.09M | ﹤0.01% |
374,046
+183,774
| +97% | +$535K |
|
|
ALPN
2887
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.08M | ﹤0.01% |
139,672
+40,865
| +41% | +$315K |
|
2888
Sweetgreen
SG
$1.03B
| $1.07M | ﹤0.01% |
+136,424
| New | +$1.07M |
|
2889
Sight Sciences
SGHT
$193M
| $1.06M | ﹤0.01% |
+121,139
| New | +$1.06M |
|
2890
Canterbury Park Holding Corp
CPHC
$84.2M
| $1.06M | ﹤0.01% |
43,225
| – | – |
|
2891
Lyft
LYFT
$7.63B
| $1.05M | ﹤0.01% |
113,637
-90,754
| -44% | -$841K |
|
2892
Mesa Air Group
MESA
$53.2M
| $1.05M | ﹤0.01% |
444,434
+69,891
| +19% | +$166K |
|
2893
Vir Biotechnology
VIR
$721M
| $1.05M | ﹤0.01% |
45,100
| – | – |
|
|
ACCS
2894
ACCESS Newswire Inc.
ACCS
$42.1M
| $1.05M | ﹤0.01% |
49,912
-1,247
| -2% | -$26.2K |
|
2895
Apyx Medical
APYX
$77.9M
| $1.05M | ﹤0.01% |
363,066
-10,043
| -3% | -$28.9K |
|
2896
Quest Resource Holding
QRHC
$36M
| $1.02M | ﹤0.01% |
165,658
+21,186
| +15% | +$130K |
|
2897
Network-1 Technologies
NTIP
$36.9M
| $1.01M | ﹤0.01% |
471,597
| – | – |
|
2898
Bank7 Corp
BSVN
$466M
| $998K | ﹤0.01% |
40,658
+7,456
| +22% | +$183K |
|
2899
Broadwind
BWEN
$45.4M
| $997K | ﹤0.01% |
259,562
-14,522
| -5% | -$55.8K |
|
2900
Jakks Pacific
JAKK
$196M
| $993K | ﹤0.01% |
+57,392
| New | +$993K |
|